日本のジェネリック医薬品産業プロファイルでは、市場規模（2018〜2023年の値、および2028年までの予測）などのトップラインの定性的および定量的概要情報が提供されます。プロファイルには、主要な財務指標や市場内の競争圧力の分析など、主要企業の説明も含まれています。
目次
Table of Contents
1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Market volume
1.4. Market volume forecast
1.5. Geography segmentation
1.6. Market rivalry
1.7. Competitive landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
3.2. Market volume
4 Market Segmentation
4.1. Geography segmentation
5 Market Outlook
5.1. Market value forecast
5.2. Market volume forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the leading players?
7.2. What are the strengths of the leading players?
7.3. Have there been any recent developments in the market?
8 Company Profiles
8.1. Toho Holdings Co Ltd
8.2. Daiichi Sankyo Co Ltd
8.3. Towa Pharmaceutical Co Ltd
8.4. Sawai Group Holdings Co Ltd
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
List of Tables
Table 1: Japan generics market value: $ million, 2018-23
Table 2: Japan generics market volume: % of total pharma volume, 2018-23
Table 3: Japan generics market geography segmentation: $ million, 2023
Table 4: Japan generics market value forecast: $ million, 2023-28
Table 5: Japan generics market volume forecast: % of total pharma volume, 2023-28
Table 6: Toho Holdings Co Ltd: Key Facts
Table 7: Toho Holdings Co Ltd: Annual Financial Ratios
Table 8: Toho Holdings Co Ltd: Key Employees
Table 9: Daiichi Sankyo Co Ltd: Key Facts
Table 10: Daiichi Sankyo Co Ltd: Annual Financial Ratios
Table 11: Daiichi Sankyo Co Ltd: Key Employees
Table 12: Daiichi Sankyo Co Ltd: Key Employees Continued
Table 13: Towa Pharmaceutical Co Ltd: Key Facts
Table 14: Towa Pharmaceutical Co Ltd: Annual Financial Ratios
Table 15: Towa Pharmaceutical Co Ltd: Key Employees
Table 16: Sawai Group Holdings Co Ltd: Key Facts
Table 17: Sawai Group Holdings Co Ltd: Annual Financial Ratios
Table 18: Sawai Group Holdings Co Ltd: Key Employees
Table 19: Japan Size of Population (million), 2019-23
Table 20: Japan Real GDP (Constant 2010 Prices, $ Billion), 2019-23
Table 21: Japan GDP (Current Prices, $ Billion), 2019-23
Table 22: Japan Inflation, 2019-23
Table 23: Japan Consumer Price Index (Absolute), 2019-23
Table 24: Japan Exchange Rate, 2018-23
List of Figures
Figure 1: Japan generics market value: $ million, 2018-23
Figure 2: Japan generics market volume: % of total pharma volume, 2018-23
Figure 3: Japan generics market geography segmentation: % share, by value, 2023
Figure 4: Japan generics market value forecast: $ million, 2023-28
Figure 5: Japan generics market volume forecast: % of total pharma volume, 2023-28
Figure 6: Forces driving competition in the generics market in Japan, 2023
Figure 7: Drivers of buyer power in the generics market in Japan, 2023
Figure 8: Drivers of supplier power in the generics market in Japan, 2023
Figure 9: Factors influencing the likelihood of new entrants in the generics market in Japan, 2023
Figure 10: Factors influencing the threat of substitutes in the generics market in Japan, 2023
Figure 11: Drivers of degree of rivalry in the generics market in Japan, 2023
